Michele Bosserman

1.5k total citations
6 papers, 792 citations indexed

About

Michele Bosserman is a scholar working on Infectious Diseases, Molecular Biology and Hepatology. According to data from OpenAlex, Michele Bosserman has authored 6 papers receiving a total of 792 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Molecular Biology and 4 papers in Hepatology. Recurrent topics in Michele Bosserman's work include Hepatitis C virus research (4 papers), HIV/AIDS drug development and treatment (4 papers) and Hepatitis B Virus Studies (2 papers). Michele Bosserman is often cited by papers focused on Hepatitis C virus research (4 papers), HIV/AIDS drug development and treatment (4 papers) and Hepatitis B Virus Studies (2 papers). Michele Bosserman collaborates with scholars based in United States, Italy and Japan. Michele Bosserman's co-authors include Steven S. Carroll, David B. Olsen, Balkrishen Bhat, Krista Getty, Anne B. Eldrup, Joanne E. Tomassini, Malcolm MacCoss, Giovanni Migliaccio, Robert L. LaFemina and Mark W. Stahlhut and has published in prestigious journals such as Journal of Biological Chemistry, Analytical Biochemistry and Journal of Virology.

In The Last Decade

Michele Bosserman

6 papers receiving 729 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michele Bosserman United States 6 453 420 305 290 100 6 792
Krista Getty United States 9 496 1.1× 360 0.9× 295 1.0× 317 1.1× 68 0.7× 11 865
Tony Whitaker United States 17 555 1.2× 436 1.0× 410 1.3× 324 1.1× 192 1.9× 36 1.0k
Stefania Lostia United States 9 461 1.0× 278 0.7× 270 0.9× 239 0.8× 110 1.1× 11 665
Linda Bartholomew Italy 11 364 0.8× 668 1.6× 505 1.7× 237 0.8× 46 0.5× 14 962
Marija Prhavc United States 11 388 0.9× 166 0.4× 275 0.9× 358 1.2× 178 1.8× 30 798
Alessandra Ceccacci Italy 7 275 0.6× 478 1.1× 357 1.2× 146 0.5× 31 0.3× 7 677
Tamara R. McBrayer United States 20 809 1.8× 514 1.2× 442 1.4× 485 1.7× 353 3.5× 47 1.3k
Hyunsoon Kang United States 9 451 1.0× 649 1.5× 495 1.6× 173 0.6× 30 0.3× 11 795
Kenneth Simmen Belgium 20 459 1.0× 753 1.8× 892 2.9× 450 1.6× 83 0.8× 39 1.6k
Jan Martin Berke Belgium 16 340 0.8× 764 1.8× 712 2.3× 183 0.6× 54 0.5× 31 1.0k

Countries citing papers authored by Michele Bosserman

Since Specialization
Citations

This map shows the geographic impact of Michele Bosserman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Bosserman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Bosserman more than expected).

Fields of papers citing papers by Michele Bosserman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele Bosserman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Bosserman. The network helps show where Michele Bosserman may publish in the future.

Co-authorship network of co-authors of Michele Bosserman

This figure shows the co-authorship network connecting the top 25 collaborators of Michele Bosserman. A scholar is included among the top collaborators of Michele Bosserman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michele Bosserman. Michele Bosserman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Nantermet, Philippe G., James C. Barrow, Stacey R. Lindsley, et al.. (2004). Imidazole acetic acid TAFIa inhibitors: SAR studies centered around the basic P 1 ′ group. Bioorganic & Medicinal Chemistry Letters. 14(9). 2141–2145. 48 indexed citations
2.
Olsen, David B., Anne B. Eldrup, Linda Bartholomew, et al.. (2004). A 7-Deaza-Adenosine Analog Is a Potent and Selective Inhibitor of Hepatitis C Virus Replication with Excellent Pharmacokinetic Properties. Antimicrobial Agents and Chemotherapy. 48(10). 3944–3953. 179 indexed citations
3.
Eldrup, Anne B., Charles Allerson, C. Frank Bennett, et al.. (2004). Structure−Activity Relationship of Purine Ribonucleosides for Inhibition of Hepatitis C Virus RNA-Dependent RNA Polymerase. Journal of Medicinal Chemistry. 47(9). 2283–2295. 153 indexed citations
4.
Mao, Shi‐Shan, Dennis Colussi, Michele Bosserman, et al.. (2003). Electrochemiluminescence assay for basic carboxypeptidases: inhibition of basic carboxypeptidases and activation of thrombin-activatable fibrinolysis inhibitor. Analytical Biochemistry. 319(1). 159–170. 27 indexed citations
5.
Carroll, Steven S., Joanne E. Tomassini, Michele Bosserman, et al.. (2003). Inhibition of Hepatitis C Virus RNA Replication by 2′-Modified Nucleoside Analogs. Journal of Biological Chemistry. 278(14). 11979–11984. 281 indexed citations
6.
Tomei, Licia, Sergio Altamura, Linda Bartholomew, et al.. (2003). Characterization of the Inhibition of Hepatitis C Virus RNA Replication by Nonnucleosides. Journal of Virology. 78(2). 938–946. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026